|
Cytoprotective and Antioxidants in Peroxisomal Neurodegenerative Diseases?DOI: https://doi.org/10.3390/proceedings2019011033 Abstract: Note: In lieu of an abstract, this is an excerpt from the first page. Several of the peroxisomal neurodegenerative disorders are the consequence of a specific deficiency of an enzyme or a transporter involved in peroxisomal beta-oxidation of very long chain fatty acids [1,2]. [...
|